By Professor Kerry-Anne Rye

Conference Papers

Van der Vorst EPC; Theodorou K; Plat J; Van Eck M; Rye KA; Bursill CA; Tas SW; De Winther MPJ; Biessen EAL; Donners MMPC, 2014, 'High density lipoproteins exert pro-inflammatory effects on macrophages via IKK2-and NIK-independent NF-kB activation', in CARDIOVASCULAR RESEARCH, OXFORD UNIV PRESS, SPAIN, Barcelona, presented at 3rd Congress of the ESC-Council-on-Basic-Cardiovascular-Science on Frontiers in Cardio Vascular Biology, SPAIN, Barcelona, 04 July 2014 - 06 July 2014, http://dx.doi.org/10.1093/cvr/cvu075.2

Tabet F; Vickers KC; Torres LFC; Ammori B; Yadav R; Hama S; Liu Y; Schofield J; Barter P; Soran H; Rye KA, 2014, 'EFFECT OF BARIATRIC SURGERY ON HDL-ASSOCIATED MICRORNAS', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E32 - E33, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014, http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.065

Weise CB; Toth CL; Landstreet SR; Taylor RC; Tabet F; Rye KA; Hofmeister LH; Harrison DG; Kon V; Vickers K, 2014, 'NOVEL HDL FUNCTIONS ASSOCIATED WITH INTERCELLULAR COMMUNICATION, ATHEROSCLEROSIS, AND CHRONIC KIDNEY DISEASE', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E22 - E22, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014, http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.032

Kontush A; Camont L; Lhomme M; Rached F; Le Goff W; Dauteuille C; Baudouin IG; Negre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Rye KA; Chapman MJ, 2014, 'PHOSPHATIDYLSERINE: A KEY PLAYER IN MULTIPLE BIOLOGICAL ACTIVITIES OF HDL', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E32 - E32, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014, http://dx.doi.org/10.1016/j.atherosclerosis.2014.05.064

Charlton FS; Bobek G; Mirabito K; Xu B; Makris A; Rye K; Hennessy A, 2013, 'THE PROTECTIVE EFFECT OF APOLIPOPROTEIN A-I ON MEAN ARTERIAL PRESSURE IN AN IN VIVO MODEL OF CYTOKINE-INDUCED HYPERTENSION IN PREGNANCY', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. E145 - E145, presented at 35th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA) / 39th Annual Scientific Meeting of the Australian-Atherosclerosis-Society (AAS), AUSTRALIA, Melbourne, 05 December 2013 - 07 December 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335491900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Lee S; Torres CL; Levin M; Drummond GR; Remaley A; Rye KA; Vickers K; Sobey CG, 2013, 'TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL CIRCUITRY IN THE BRAIN AFTER TRANSIENT AND PERMANENT ISCHEMIA', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. E157 - E158, presented at 35th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA) / 39th Annual Scientific Meeting of the Australian-Atherosclerosis-Society (AAS), AUSTRALIA, Melbourne, 05 December 2013 - 07 December 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335491900076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bisoendial R; Roediger B; Jain R; Cavanagh L; Tak P-P; Rye K-A; Weninger W, 2013, 'TARGETING LYMPHATIC DYSFUNCTION IN RHEUMATOID ARTHRITIS BY HIGH-DENSITY LIPOPROTEIN', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, pp. 195 - 195

Arsenault BJ; Huijgen R; Boekholdt SM; Bao W; Tabet F; Petrides F; Rye K-A; DeMicco DA; Barter PJ; Kastelein JJ; Lambert G, 2011, 'Plasma PCSK9 Levels and Clinical Outcomes in the Treating to New Targets Trial: A Nested Case-Control Study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000299738706056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Charlton F; Xu B; Makris A; Rye K; Hennessy A, 2011, 'High density lipoproteins restore integrin switching in a model of pre-eclampsia', in Placenta, W B Saunders Company Ltd, London, England, pp. A94 - A94, presented at Meeting of the International-Federation-of-Placenta-Associations (IFPA), Geilo NORWAY, 14 September 2011 - 17 September 2011

Charlton F; Xu B; Makris A; Rye K; Hennessy A, 2011, 'Protective effects of high density lipoproteins in a model of pre-eclampsia', in Placenta, W B Saunders Company Ltd, London, England, pp. A94 - A94, presented at Meeting of the International-Federation-of-Placenta-Associations (IFPA), Geilo NORWAY, 14 September 2011 - 17 September 2011

Fryirs MA; Barter PJ; Appavoo M; Tuch B; Tabet F; Heater AK; Rye KA, 2009, 'High Density Lipoproteins Increase the Insulin Secretory Capacity of Pancreatic beta-Cells', in DIABETES, AMER DIABETES ASSOC, LA, New Orleans, pp. A426 - A426, presented at 69th Annual Meeting of the American-Diabetes-Association, LA, New Orleans, 05 June 2009 - 09 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000266352602394&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fryirs M; Barter P; Tabet F; Heather A; Rye K, 2009, 'HIGH DENSITY LIPOPROTEINS (HDL) INCREASE PANCREATIC B-CELL INSULIN SECRETION', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Heather A; Li X-H; McGrath K; Rye K; Barter P, 2009, 'HIGH DENSITY LIPOPROTEINS (HDLS) INDUCE A MILD OXIDATIVE STRESS RESPONSE IN HUMAN ENDOTHELIAL CELLS THAT INCREASES CELLULAR ANTIOXIDANT PROTEIN EXPRESSION AND PROTECTS AGAINST INFLAMMATORY INSULT', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liong E; McGrath K; Tan J; Li X-H; Dy V; Barter P; Rye K; Heather A, 2009, 'ROLE OF 3B-HYDROXYSTEROID-[DELTA]24 REDUCTASE IN MEDIATING THE ANTI-INFLAMMATORY EFFECTS OF HIGH-DENSITY LIPOPROTEINS IN ENDOTHELIAL CELLS', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101118&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Remaley A; Barter P; Rye K-A; Lambert G, 2009, 'THE 5A APOA-I MIMETIC PEPTIDE DISPLAYS ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES MEDIATED BY ABCA1', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101675&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Lambert G; Jenkins A; Barter P; Rye K-A, 2009, 'THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957100913&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tabet F; Barter PJ; Rye K-A, 2008, 'Apolipoprotein A-I and reconstituted high-density lipoproteins inhibit NADPH oxidase activation and expression and increase superoxide dismutase levels in human macrophages in high glucose conditions', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, GA, Atlanta, pp. E87 - E87, presented at 9th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, GA, Atlanta, 16 April 2008 - 18 April 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256053400306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Uehara Y; Zhang B; Tsuboi Y; Miura S; Abe S; Higuchi M; Urata H; Rye KA; Yamada T; Saku K, 2006, 'A novel therapeutic strategy for Tangier disease', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 562 - 562, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006, http://dx.doi.org/10.1016/S1567-5688(06)82269-5

Gelissen I; Harris M; Rye KA; Quinn CM; Brown AJ; Kockx M; Cartland S; Packianathan M; Kritharides L; Jessup W, 2006, 'ABCA1 and ABCG1 act sequentially to mediate cholesterol export to apoA-I', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 541 - 541, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006, http://dx.doi.org/10.1016/S1567-5688(06)82178-1

Taylor J; Rye KA; Sloane T; Gaus K; Ruberu K; Jessup W; Kritharides L, 2006, 'Exogenous apolipoprotein A-I promotes faecal sterol excretion in hypercholesterolemic rabbits', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 167 - 167, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006, http://dx.doi.org/10.1016/S1567-5688(06)80653-7

Barter PJ; Rye KA, 2006, 'The rationale for using apoA-I as a clinical marker of cardiovascular risk', in Journal of Internal Medicine, pp. 447 - 454, http://dx.doi.org/10.1111/j.1365-2796.2006.01647.x

Kockx M; Wright J; Sloane T; Sviridov D; Fu Y; Chaddha M; Anantharamaiah G; Phillips M; Dean R; Rye K; Jessup W; Kritharides L, 2003, 'Apolipoprotein A-I-mediated secretion of apolipoprotein E has structural requirements distinct from those related to stimulation of cholesterol efflux', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, JAPAN, KYOTO, pp. 70 - 71, presented at 13th International Symposium on Atherosclerosis, JAPAN, KYOTO, 28 September 2003 - 02 October 2003, http://dx.doi.org/10.1016/S1567-5688(03)90303-5

James M; vanReyk D; Rye K; Dean R; Cleland L; Barter P; Jessup W, 1998, 'Low density lipoprotein (LDL) in human inflammatory joint fluid.', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A487 - A487, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076006402828&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barter PJ; Chang LBF; Newnham HH; Rye KA; Rajaram OV, 1990, 'Roles of lecithin: Cholesterol acyltransferase, lipid transfer proteins and nonesterified fatty acids in plasma cholesterol transport', in Journal of Drug Development, Supplement, pp. 85 - 89

Conference Presentations

Manandhar B; Cochran BJ; Rye K, 2019, 'APOLIPOPROTEIN A-I LOCALISES TO MITOCHONDRIA AND INHIBITS ROS GENERATION IN INSULIN PRODUCING CELLS.', presented at AAS 2019 Annual Scientific meeting, Victoria University City Convention Centre, Melbourne, 16 October 2019 - 19 October 2019

Tucker B; Rehan R; Vaidya K; Rye K; Cochran B; Patel S, 2019, 'Colchicine inhibits neutrophil extracellular trap formation in acute coronary syndrome patients', presented at Australian Atherosclerosis Society Annual Scientific Meeting, Melbourne, 16 October 2019 - 19 October 2019

Tan WT; Kopecky C; Manandhar B; Rye K-A; Cochran B, 2019, 'Skeletal Muscle Specific Deletion Of Abca1 And Abcg1 Impacts Body Composition And Metabolism And Is Age Dependent', presented at 87th European Atherosclerosis Society Congress, 26 May 2019, http://dx.doi.org/10.1016/j.atherosclerosis.2019.06.122

Conference Abstracts

Ong KL; McClelland R; Allison MA; Cushman M; Garg P; Tsai MY; Rye KA; Tabet F, 2020, 'Association of Lipoprotein (a) and Coronary Artery Calcification: Prospective Study Assessing Interactions With Other Risk Factors in the Multi-Ethnic Study of Atherosclerosis', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 142

Vaidya K; Tucker B; Khandkar C; Pandzic E; Barraclough J; Misra A; Kavurma M; Rye K-A; Patel S; Cochran BJ, 2020, 'Colchicine Inhibits Neutrophil Extracellular Trap Formation in Acute Coronary Syndrome Patients Post Percutaneous Coronary Intervention', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 40, presented at American-Heart-Association's Scientific Sessions on Vascular Discovery - From Genes to Medicine, ELECTR NETWORK, 05 May 2020 - 07 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000607042600203&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kopecky C; Ryder WJ; Szajer J; Parmar A; Pandzic E; Rye K-A; Cochran BJ, 2018, 'The TSPO Radioligand 18F-PBR111 as a Pre-Atherosclerotic Lesion Detection Agent', in Atherosclerosis Plus, Elsevier, CANADA, Toronto, Vol. 32, pp. 145 - 146, presented at International Symposium on Atherosclerosis (ISA), CANADA, Toronto, 09 June 2018 - 12 June 2018, http://dx.doi.org/10.1016/j.atherosclerosissup.2018.04.446

Cochran BJ; Pinheiro D; Prendecki M; Jones B; Cegla J; Lee V; Barter PJ; Murphy AJ; Rye K-A; Woollard KJ, 2018, 'PRO-ATHEROSCLEROTIC LOW-DENSITY NEUTROPHILS ARE PRESENT IN HYPERCHOLESTEROLEMIA', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, CANADA, Toronto, Vol. 32, pp. 39 - 40, presented at International Symposium on Atherosclerosis (ISA), CANADA, Toronto, 09 June 2018 - 12 June 2018, http://dx.doi.org/10.1016/j.atherosclerosissup.2018.04.115

Wu BJ; Sun Y; Tang S; Ong KL; Barter PJ; Rye K, 2017, 'Apolipoprotein A-I Protects against Pregnancy-Induced Insulin Resistance in Rats', in DIABETES, AMER DIABETES ASSOC, CA, San Diego, Vol. 66, pp. A32 - A32, presented at 77th Scientific Sessions of the American-Diabetes-Association, CA, San Diego, 09 June 2017 - 13 June 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408064100126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ong KL; O'Connell R; Januszewski AS; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Waldman B; Colman PG; Best JD; Simes JR; Rye KA; Keech AC, 2017, 'Baseline Circulating FGF-21 Levels and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study', in DIABETES, AMER DIABETES ASSOC, CA, San Diego, Vol. 66, pp. A458 - A458, presented at 77th Scientific Sessions of the American-Diabetes-Association, CA, San Diego, 09 June 2017 - 13 June 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408064103220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cochran BJ; Hou L; Manavalan APC; Sultana A; Moore BM; Patel M; Tall A; Barter PJ; Rye KA, 2015, 'PANCREATIC BETA-CELL SPECIFIC DELETION OF ABCA1 AND ABCG1 PERTURBS GLUCOSE METABOLISM AND INCREASES ADIPOSITY IN MICE DUE TO SUBOPTIMAL PLASMA INSULIN LEVELS', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SCOTLAND, Glasgow, Vol. 241, pp. E3 - E3, presented at 83rd Congress of the European-Atherosclerosis-Society (EAS), SCOTLAND, Glasgow, 22 March 2015 - 25 March 2015, http://dx.doi.org/10.1016/j.atherosclerosis.2015.04.028

Ong KL; Januszewski AS; O'Connell R; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Hung WT; Keech AC; Rye K-A, 2014, 'Fibroblast Growth Factor 21 and Cardiovascular Outcome Events in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study', in DIABETES, AMER DIABETES ASSOC, Vol. 63, pp. A295 - A295, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359481601456&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ong KL; Allison MA; Cheung BMY; Wu BJ; Barter PJ; Rye K-A, 2012, 'C-Reactive Protein Trends and Associations with Total Mortality in United States Adults between 1999-2010', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885000078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wu BJ; Shrestha S; Ong KL; Johns DG; Barter PJ; Rye K-A, 2012, 'Effects of Cholesteryl Ester Transfer Protein Inhibition on Endothelial Repair and Function', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885001039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ong KL; Rye K-A; O'Connell R; Jenkins AJ; Brown C; Xu A; Sullivan DR; Barter PJ; Keech AC, 2012, 'Long-term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-binding Protein 4 in Subjects With Type 2 Diabetes', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885001409&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ong KL; Wu BJ; Cheung BMY; Barter PJ; Rye K-A, 2011, 'Arthritis: Its Prevalence, Risk Factors, and Association with Cardiovascular Diseases in the United States National Health and Nutrition Examination Survey 1999-2008', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000299738703116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Preprints

Manandhar B; Pandzic E; Deshpande N; Chen S-Y; Wasinger V; Kockx M; Glaros E; Ong KL; Thomas SR; Wilkins MR; Whan RM; Cochran BJ; Rye K-A, 2023, ApoA-I Protects Pancreatic β-cells from Cholesterol-induced Mitochondrial Damage and Restores their Ability to Secrete Insulin, , http://dx.doi.org/10.1101/2023.04.03.535492

Richardson A; Fok S; Lee V; Rye K-A; Di Girolamo N; Cochran B, 2021, Use of high-refractive index hydrogels and tissue clearing for large biological sample imaging (Preprint), , http://dx.doi.org/10.2196/preprints.31794

Tucker B; Sawant S; McDonald H; Rye K-A; Patel S; Ong KL; Cochran BJ, 2020, The Association of Serum Lipid and Lipoprotein Levels with Total and Differential Leukocyte Counts: Results of a Cross-sectional and Longitudinal Analysis of the UK Biobank, , http://dx.doi.org/10.1101/2020.07.11.20149310

Vaidya K; Tucker B; Kurup R; Khandkar C; Pandzic E; Barraclough J; Machet J; Misra A; Kavurma M; Martinez G; Rye K-A; Cochran BJ; Patel S, 2020, Colchicine inhibits neutrophil extracellular trap formation in acute coronary syndrome patients after percutaneous coronary intervention, , http://dx.doi.org/10.1101/2020.04.20.20034025

Richardson A; Fok S; Lee V; Rye K-A; Di Girolamo N; Cochran BJ, 2020, Use of high-refractive index hydrogels and tissue clearing for large biological sample imaging, , http://dx.doi.org/10.1101/2020.01.22.905695

Lai YC; Woollard KJ; McClelland RL; Allison MA; Rye K-A; Ong KL; Cochran BJ, 2018, The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis, , http://dx.doi.org/10.1101/488023

Kopecky C; Pandzic E; Parmar A; Szajer J; Lee V; Dupuy A; Arthur A; Fok S; Whan R; Ryder WJ; Rye K-A; Cochran BJ, 2018, Translocator Protein Localises To CD11b+ Macrophages In Atherosclerosis, , http://dx.doi.org/10.1101/494377

Back to profile page